bcl-2 Induction of Urokinase Plasminogen Activator Receptor Expression in Human Cancer Cells through Sp1 Activation
Open Access
- 1 February 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (8) , 6737-6745
- https://doi.org/10.1074/jbc.m308938200
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Oncogenes and Angiogenesis: Signaling Three-Dimensional Tumor GrowthJournal of Investigative Dermatology Symposium Proceedings, 2000
- Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of functionOncogene, 2000
- Bcl‐2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression andin vivoangiogenesis in a breast carcinoma lineThe FASEB Journal, 2000
- Role and Localization of Urokinase Receptor in the Formation of New Microvascular Structures in Fibrin MatricesThe American Journal of Pathology, 1999
- Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastomaOncogene, 1999
- Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor β-1Annals of Surgical Oncology, 1998
- Hypoxic induction of human vascular endothelial growth factor expression through c-Src activationNature, 1995
- Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.Proceedings of the National Academy of Sciences, 1994
- Hypoxic induction of interleukin-8 gene expression in human endothelial cells.Journal of Clinical Investigation, 1994
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992